Establishes an emergency insulin program and corresponding emergency insulin program trust fund to facilitate emergency access to analog insulins.
Impact
The implementation of this bill could lead to a substantial shift in the management of diabetes care within the state, especially for uninsured and underinsured individuals. By establishing an official program through state law, it not only provides a safety net for those at risk of severe health complications from insulin deficiency but also obligates the state to monitor and report the program's effectiveness periodically. This initiative could serve as a model for other states addressing similar public health concerns.
Summary
Bill S01917 introduces an Emergency Insulin Program in New York, aimed at ensuring individuals, particularly those diagnosed with insulin-dependent diabetes, have access to emergency supplies of analog insulins. The bill mandates the establishment of a trust fund to support this program, facilitating quick access to affordable insulin in emergency situations. It directs the Commissioner of Health to engage with insulin manufacturers to enhance availability and affordability, reflecting a significant step toward improving public health outcomes for diabetic patients.
Contention
While the bill has garnered support for addressing the urgent need for insulin availability, there are potential points of contention, particularly concerning budget allocations and the sustainability of the trust fund. Critics may voice concerns regarding the reliance on public-private partnerships and whether this approach adequately guarantees long-term solutions for those dependent on insulin. Ensuring that the program does not become a temporary fix but rather a permanent fixture in the state’s healthcare system will be essential for its success.
Same As
Establishes an emergency insulin program and corresponding emergency insulin program trust fund to facilitate emergency access to analog insulins.